How Could We Establish Monitoring and Surveillance of Health-Harming Corporations and Can Governments Be Trusted to Do It?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis”

Document Type : Commentary

Authors

1 Tobacco Control Research Group, Department for Health, Faculty of Humanities and Social Sciences, University of Bath, Bath, UK

2 Centre for 21st Century Public Health, University of Bath, Bath, UK

3 School of Nursing, University of California, San Francisco, CA, USA

4 Global Cancer Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA

Abstract

In the context of growing interest in the commercial determinants of health (CDOH) which has been defined as “the systems, practices, and pathways through which commercial actors drive health and equity,” Bennett et al propose that governments implement monitoring of unhealthy commodity industries (UCIs) (including tobacco, alcohol, and ultra-processed foods) as part of their routine public health surveillance. We explore the evidence underpinning that suggestion and provide details on how corporate monitoring might be practically implemented drawing on lessons from tobacco industry monitoring which has been an established part of tobacco control. While governments should actively support such an approach as part of efforts to address commercially driven health harms, we urge caution in governments undertaking monitoring and identify significant barriers to implementation, while also suggesting ways in which those barriers might be overcome. 

Keywords

References

  1. Gilmore AB, Fabbri A, Baum F, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023;401(10383):1194-1213. doi:1016/s0140-6736(23)00013-2
  2. Friel S, Collin J, Daube M, et al. Commercial determinants of health: future directions. Lancet. 2023;401(10383):1229-1240. doi:1016/s0140-6736(23)00011-9
  3. Bennett E, Topp SM, Moodie AR. National Public Health Surveillance of Corporations in key unhealthy commodity industries - a scoping review and framework synthesis. Int J Health Policy Manag. 2023;12:6876. doi:34172/ijhpm.2023.6876
  4. Madureira Lima J, Galea S. Corporate practices and health: a framework and mechanisms. Global Health. 2018;14(1):21. doi:1186/s12992-018-0336-y
  5. Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, et al. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ Open. 2020;10(7):e034082. doi:1136/bmjopen-2019-034082
  6. Legg T, Hatchard J, Gilmore AB. The science for profit model-how and why corporations influence science and the use of science in policy and practice. PLoS One. 2021;16(6):e0253272. doi:1371/journal.pone.0253272
  7. Ulucanlar S, Lauber K, Fabbri A, et al. Corporate political activity: taxonomies and model of corporate influence on public policy. Int J Health Policy Manag. 2023;12:7292. doi:34172/ijhpm.2023.7292
  8. Savell E, Gilmore AB, Fooks G. How does the tobacco industry attempt to influence marketing regulations? A systematic review. PLoS One. 2014;9(2):e87389. doi:1371/journal.pone.0087389
  9. Mialon M, Swinburn B, Sacks G. A proposed approach to systematically identify and monitor the corporate political activity of the food industry with respect to public health using publicly available information. Obes Rev. 2015;16(7):519-530. doi:1111/obr.12289
  10. Ghebreyesus TA. Achieving health for all requires action on the economic and commercial determinants of health. Lancet. 2023;401(10383):1137-1139. doi:1016/s0140-6736(23)00574-3
  11. Tobacco Tactics. Tobacco Control Research Group: TIMRA Model. https://tobaccotactics.org/article/tobacco-control-research-group-timra-model/. Updated August 13, 2024. Accessed August 14, 2024.
  12. Gilmore A, Dance S. Learning from 70 years of tobacco control: winning the war and not just the battles. In: Maani N, Petticrew M, Galea S, eds. The Commercial Determinants of Health. Oxford University Press; 2022.
  13. Bero L. Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health. 2003;24:267-288. doi:1146/annurev.publhealth.24.100901.140813
  14. Tobacco Tactics. FCTC Regulations on the Need to Protect Public Health Policies from Tobacco Industry Interference. 2022. https://tobaccotactics.org/article/fctc-regulations-protect-public-health-policies-interference/. Updated December 16, 2022. Accessed August 14, 2024.
  15. Gilmore AB, Fooks G, Drope J, Bialous SA, Jackson RR. Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet. 2015;385(9972):1029-1043. doi:1016/s0140-6736(15)60312-9
  16. Tobacco Tactics. Tobacco Control Research Group: Policy Impact. 2018. https://tobaccotactics.org/article/tobacco-control-research-group-policy-impact/. Updated August 13, 2024. Accessed August 14, 2024.
  17. Ralston R, Bialous S, Collin J. Firm foundation or neglected cornerstone? The paradox of Article 5.3 implementation and the challenge of strengthening tobacco control governance. Tob Control. 2022;31(Suppl 1):s1-s4. doi:1136/tobaccocontrol-2022-057344
  18. World Health Organization (WHO). 2023 Global Progress Report on Implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO; 2023. https://fctc.who.int/publications/m/item/2023-global-progress-report.
  19. Assunta M. Global Tobacco Industry Interference Index 2023. Bangkok, Thailand: Global Center for Good Governance in Tobacco Control (GGTC); 2023. https://globaltobaccoindex.org/report-summary.
  20. Matthes BK, Alebshehy R, Gilmore AB. "They try to suppress us, but we should be louder": a qualitative exploration of intimidation in tobacco control. Global Health. 2023;19(1):88. doi:1186/s12992-023-00991-0

Files

History

  • Receive Date: 04 June 2024
  • Revise Date: 30 August 2024
  • Accept Date: 31 August 2024
  • First Publish Date: 01 September 2024

Share

How to cite

Statistics